Display options
Share it on

JAAD Case Rep. 2017 Feb 03;3(1):67-69. doi: 10.1016/j.jdcr.2016.12.005. eCollection 2017 Jan.

Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus.

JAAD case reports

Umer Ansari, Lauren I Henderson, Geraldine Stott, Karina Parr

Affiliations

  1. Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia.
  2. Department of Infectious Disease, Eastern Virginia Medical School, Norfolk, Virginia.
  3. Department of Dermatology, Hampton Veterans Affairs Medical Center, Hampton, Virginia.

PMID: 28229123 PMCID: PMC5311428 DOI: 10.1016/j.jdcr.2016.12.005

[No abstract available.]

Keywords: DAA, direct antiviral agents; HCV, hepatitis C virus; Harvoni; LP, lichen planus; hepatitis C; ledipasvir-sofosbuvir; lichen planus

References

  1. J Cutan Pathol. 2016 Apr;43(4):408-9 - PubMed
  2. Cutan Ocul Toxicol. 2016 Jul 15;:1-2 - PubMed
  3. Oral Dis. 2010 Oct;16(7):601-12 - PubMed
  4. World J Hepatol. 2015 Nov 28;7(27):2740-8 - PubMed
  5. Pharmacotherapy. 2016 May;36(5):562-74 - PubMed
  6. Dermatol Ther. 2016 Jan-Feb;29(1):7-9 - PubMed
  7. J Clin Transl Hepatol. 2015 Jun 28;3(2):127-33 - PubMed

Publication Types